Browsing Tag
Vaxcyte Inc.
2 posts
Pneumococcal vaccine strategy shifts toward scale and integration with Vaxcyte Inc.’s VAX-31 Phase 3 push
Vaxcyte Inc. advances VAX-31 into pivotal trials. Find out what this means for vaccine competition, regulation, and long-term market positioning.
Why did Corcept, Johnson & Johnson, and Southwest Airlines fall on April 1, 2025?
Corcept, Johnson & Johnson, and Southwest Airlines lead US stock losses as biotech and airline sectors react to trade policy jitters on April 1, 2025.